Results 1 to 10 of about 2,560 (200)

Near-Infrared Photoimmunotherapy for Oropharyngeal Cancer

open access: yesCancers, 2022
Human papillomavirus (HPV)-associated oropharyngeal cancer has a better prognosis than other head and neck cancers. However, rates of recurrence and metastasis are similar and the prognosis of recurrent or metastatic HPV-associated oropharyngeal cancer is poor.
Hidenori Suzuki   +2 more
exaly   +4 more sources

Near Infrared Photoimmunotherapy for Lung Metastases [PDF]

open access: yesCancer Letters, 2015
Lung metastases are a leading cause of cancer related deaths; nonetheless current treatments are limited. Near infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of intravenously injected antibodies that target tumors with the toxicity induced by photosensitizers activated by NIR-light.
Tadanobu Nagaya   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Photoimmunotherapy for Head and Neck Cancer: A Systematic Review

Auris Nasus Larynx
Photoimmunotherapy is a new cancer treatment that uses cetuximab sarotalocan sodium, a conjugate of cetuximab and the light activatable dye, IR700, and red light at a wavelength of 690 nm. In Japan, photoimmunotherapy for "unresectable locally advanced or locally recurrent head and neck cancer" has been covered by insurance since 2021.
Isaku Okamoto
exaly   +3 more sources

Optical Functional Nanomaterials for Cancer Photoimmunotherapy

Coordination Chemistry Reviews
Xiaochen Dong, Longcai Liu, Luyi Ye
exaly  

Home - About - Disclaimer - Privacy